Parkinson’s disease (PD), the second most prevalent neurodegenerative disorder worldwide, is characterized by the progressive degeneration of dopaminergic neurons in the substantia nigra, leading to a ...

More data, this time from a large observational study, are bolstering the idea that glucagon-like peptide-1 (GLP-1) receptor agonists offer neuroprotective and cerebrovascular benefits beyond what can ...

For adults with type 2 diabetes and obesity, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a lower risk for dementia, stroke, and all-cause mortality compared with other ...

Former FDA chief Dr. David Kessler says the new weight-loss drugs are a powerful tool to fight obesity. But they come with pitfalls. Here's his tips for how to use them successfully.

People with diabetes who were taking GLP-1 drugs had a low but elevated risk of an age-related eye disease that can sometimes lead to blindness, adding to a short list of concerns about eye health ...

Protein isn’t just fuel, it’s a GLP-1 amplifier. Every time you eat a protein-rich meal, you’re telling your body to produce more of this fat-fighting hormone.

But don’t race to ask your doctor for a dual prescription just yet, she says. While Faubion’s initial research suggests that combining MHT and a GLP-1 may help with weight loss, more studies ...

Over three years of follow-up between 2020 and 2023, 0.2% (93 patients) of those in the GLP-1 user group were diagnosed with nAMD, as were 0.1% (88 patients) in the contrasting group.

3. On GLP-1 drugs, get comfortable with being uncomfortable. The great thing about these drugs, says Kessler, is that they allow you to relearn how to eat. But that comes with some caveats. GLP-1 ...